1297 related articles for article (PubMed ID: 18044472)
1. [Topical corticosteroids and corticosteroid sparing therapy in psoriasis management].
Sukarovska BG; Lipozencić J; Vrzogić P
Acta Med Croatica; 2007 Sep; 61(4):375-81. PubMed ID: 18044472
[TBL] [Abstract][Full Text] [Related]
2. A clinician's paradigm in the treatment of psoriasis.
Lebwohl M
J Am Acad Dermatol; 2005 Jul; 53(1 Suppl 1):S59-69. PubMed ID: 15968265
[TBL] [Abstract][Full Text] [Related]
3. Topical management of psoriasis - corticosteroids and sparing corticosteroid therapy.
Gorgievska Sukarovska B; Lipozencić J
Acta Dermatovenerol Croat; 2006; 14(3):188-96. PubMed ID: 17010269
[TBL] [Abstract][Full Text] [Related]
4. Advances in psoriasis treatment.
Feldman S
Dermatol Online J; 2000 Sep; 6(1):4. PubMed ID: 11328614
[TBL] [Abstract][Full Text] [Related]
5. Use of retinoids in the treatment of psoriasis.
Warren EW; Khanderia U
Clin Pharm; 1989 May; 8(5):344-51. PubMed ID: 2663325
[TBL] [Abstract][Full Text] [Related]
6. Psoriasis treatment in difficult locations: scalp, nails, and intertriginous areas.
Wozel G
Clin Dermatol; 2008; 26(5):448-59. PubMed ID: 18755363
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of treatment modalities for psoriasis.
Tristani-Firouzi P; Krueger GG
Cutis; 1998 Feb; 61(2 Suppl):11-21. PubMed ID: 9787987
[TBL] [Abstract][Full Text] [Related]
8. Childhood psoriasis.
Dogra S; Kaur I
Indian J Dermatol Venereol Leprol; 2010; 76(4):357-65. PubMed ID: 20657115
[TBL] [Abstract][Full Text] [Related]
9. [Psoriasis].
Pinto GM; Gonçalo MM; Resende C; Pereira A
Acta Med Port; 2001; 14(2):219-45. PubMed ID: 11475988
[TBL] [Abstract][Full Text] [Related]
10. Combination therapy to treat moderate to severe psoriasis.
Lebwohl M; Menter A; Koo J; Feldman SR
J Am Acad Dermatol; 2004 Mar; 50(3):416-30. PubMed ID: 14988684
[TBL] [Abstract][Full Text] [Related]
11. Calcitriol 3 microg/g ointment: an effective and safe addition to the armamentarium in topical psoriasis therapy.
Abramovits W
J Drugs Dermatol; 2009 Aug; 8(8 Suppl):s17-22. PubMed ID: 19702032
[TBL] [Abstract][Full Text] [Related]
12. Psoriasis therapy: a current perspective.
Lowe NJ
West J Med; 1983 Aug; 139(2):184-9. PubMed ID: 6195826
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of topical calcitriol 3 microg/g ointment, a new topical therapy for chronic plaque psoriasis.
Kircik L
J Drugs Dermatol; 2009 Aug; 8(8 Suppl):s9-16. PubMed ID: 19702031
[TBL] [Abstract][Full Text] [Related]
14. Neutrophilic dermatoses: a review of current treatment options.
Cohen PR
Am J Clin Dermatol; 2009; 10(5):301-12. PubMed ID: 19658442
[TBL] [Abstract][Full Text] [Related]
15. Modifications of PUVA.
Momtaz-T K; Fitzpatrick TB
Dermatol Clin; 1995 Oct; 13(4):867-73. PubMed ID: 8785890
[TBL] [Abstract][Full Text] [Related]
16. Treatment of psoriasis.
Bryant BG
Am J Hosp Pharm; 1980 Jun; 37(6):814-20. PubMed ID: 6994496
[TBL] [Abstract][Full Text] [Related]
17. Limited application of fluticasone propionate ointment, 0.005% in patients with psoriasis of the face and intertriginous areas.
Lebwohl MG; Tan MH; Meador SL; Singer G
J Am Acad Dermatol; 2001 Jan; 44(1):77-82. PubMed ID: 11148481
[TBL] [Abstract][Full Text] [Related]
18. Tacrolimus ointment is effective for facial and intertriginous psoriasis.
Lebwohl M; Freeman AK; Chapman MS; Feldman SR; Hartle JE; Henning A;
J Am Acad Dermatol; 2004 Nov; 51(5):723-30. PubMed ID: 15523350
[TBL] [Abstract][Full Text] [Related]
19. 1% pimecrolimus, 0.005% calcipotriol, and 0.1% betamethasone in the treatment of intertriginous psoriasis: a double-blind, randomized controlled study.
Kreuter A; Sommer A; Hyun J; Bräutigam M; Brockmeyer NH; Altmeyer P; Gambichler T
Arch Dermatol; 2006 Sep; 142(9):1138-43. PubMed ID: 16983001
[TBL] [Abstract][Full Text] [Related]
20. Class I topical corticosteroid use by psoriasis patients in an academic practice.
Pearce DJ; Spencer L; Hu J; Balkrishnan R; Fleischer AB; Feldman SR
J Dermatolog Treat; 2004 Jul; 15(4):235-8. PubMed ID: 15764038
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]